600409:SSETangshan Sanyou Chemical Industries Co., Ltd. Class A Analysis
Data as of 2026-05-29 - not real-time
CN¥6.22
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Tangshan Sanyou Chemical is trading at a **PE ratio of 622**, far above the forward PE of 15.5, indicating a severe overvaluation relative to its earnings outlook. The company’s revenue has contracted by 5.4% and margins are thin, with a gross margin of just 11.6% and an operating loss, while free cash flow is negative, raising concerns about earnings sustainability. Technical signals are mixed: the 20‑day SMA (7.15) sits above the current price (6.22) and the RSI of 31 suggests the stock is oversold, yet the MACD remains bearish and volume is on a decreasing trend, hinting at limited buying pressure. The dividend yield of 1.14% appears attractive, but the payout ratio of only 8.8% is supported by minimal earnings, making the dividend’s durability questionable.
Given the high volatility (44% 30‑day) and a beta near zero, price movements appear driven more by company‑specific factors than market swings. Sector exposure to specialty chemicals adds medium regulatory and geographic risk, while the decreasing trading volume points to moderate liquidity concerns. Overall, the stock’s fundamentals do not justify its current price, and the outlook remains uncertain without a clear turnaround in profitability.
Given the high volatility (44% 30‑day) and a beta near zero, price movements appear driven more by company‑specific factors than market swings. Sector exposure to specialty chemicals adds medium regulatory and geographic risk, while the decreasing trading volume points to moderate liquidity concerns. Overall, the stock’s fundamentals do not justify its current price, and the outlook remains uncertain without a clear turnaround in profitability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- extremely high trailing PE
- oversold RSI but bearish MACD
- decreasing volume indicating weaker liquidity
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential earnings improvement reflected in forward PE
- modest dividend yield with low payout ratio
- ongoing sector cyclicality and regulatory exposure
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- persistent negative free cash flow
- valuation gap between market price and DCF fair value
- structural profitability challenges and high volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-5.40%
Profit Margin0.09%
P/E Ratio622.0
ROE-0.23%
ROA0.08%
Debt/Equity42.75
P/B Ratio0.9
Op. Cash FlowCN¥694.2M
Free Cash FlowCN¥-156264224
Technical Analysis
TrendNeutral
RSI31.4
SupportCN¥6.19
ResistanceCN¥8.03
MA 20CN¥7.15
MA 50CN¥7.18
MA 200CN¥6.62
MACDBearish
VolumeDecreasing
Fear & Greed Index93.32
Valuation
Fair ValueCN¥1.42
GradeOvervalued
TypeValue
Dividend Yield1.14%
Risk Assessment
Beta-0.10
Volatility44.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.